세계의 실시간 혈당 측정 CGM 패치 시장 보고서(2025년)
Real-Time Blood Glucose CGM Patch Global Market Report 2025
상품코드 : 1877861
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

실시간 혈당 측정 CGM 패치 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 64억 1,000만 달러로 평가되었고, 2025년에는 70억 5,000만 달러에 달하고, CAGR 10.1%로 성장할 것으로 전망되고 있습니다. 지난 수년간의 성장은 당뇨병 환자 증가, 웨어러블 의료기기의 보급 확대, 저침습형 혈당 모니터링 솔루션에 대한 수요 증가, 당뇨병 관리 및 자기 모니터링에 대한 의식 증가로 인한 것으로 예측됩니다.

실시간 혈당 측정 CGM 패치 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 104억 7,000만 달러에 달하고, CAGR은 10.4%를 나타낼 전망입니다. 예측 기간 동안의 성장은 원격 환자 모니터링 및 원격 의료 솔루션에 대한 수요 증가, 개인화된 의료 솔루션에 대한 소비자 관심 증가, 가정 의료 모니터링의 선호 확대, 예방 의료 및 조기 개입에 대한 주목 증가, 기존 방법에 대한 지속적인 혈당 모니터링의 이점에 대한 인식 향상에 의해 견인됩니다. 예측기간의 주요 동향으로는 개별화 당뇨병 관리 플랫폼의 개발, 원격 환자 모니터링을 위한 원격 의료 시스템과의 통합, 종합적인 건강 분석을 위한 피트니스 트래커와의 제휴, 장시간의 착용과 피부에의 쾌적성을 실현하는 생체 적합성 재료의 혁신, 원활한 임상의 모니터링을 위한 전자 건강 기록(EHR)과

원격 모니터링 및 원격 의료 도입 확대는 향후 수년간 실시간 혈당 측정 CGM 패치 시장의 성장을 가속할 것으로 예측됩니다. 원격 모니터링이란 혈당, 심박수, 혈압 등의 환자 건강 데이터를 기존의 임상 환경 밖에서 의료 제공업체에게 수집·송신하고 지속적인 평가와 관리를 하는 디지털 기술의 이용을 말합니다. 원격 의료 도입에는 비디오 진단, 원격 후속 조치, 환자와 의료 제공업체 간의 디지털 통신을 포함한 가상 의료 서비스의 사용 확대가 포함됩니다. 특히 당뇨병 등의 만성질환 관리에 있어서 편리하고 접근하기 쉬운 의료서비스에 대한 수요가 높아지면서 원격 모니터링과 원격의료 도입이 증가하고 있습니다. 실시간 혈당 측정 CGM 패치는 의료 제공업체와 지속적이고 실시간 데이터 공유를 가능하게 하고 적시에 개입하고 효과적인 가상 당뇨병 관리를 실현함으로써 이러한 동향을 지원합니다. 예를 들어 미국 전국 조직인 미국 병원 협회(AHA)에 따르면 2025년 2월 현재 미국은 2036년까지 최대 8만 6,000명의 의사 부족에 직면할 것으로 예측되고 있으며, 이 의료 격차를 해소하는데 있어서 원격 의료가 수행하는 중요한 역할이 강조되고 있습니다. 따라서 원격 모니터링 및 원격 의료 도입 증가는 실시간 혈당 측정 CGM 패치 시장의 성장을 가속하고 있습니다.

실시간 혈당 측정 CGM 패치 시장에서 활동하는 주요 기업은 사용자 편의성 향상과 신뢰성 높은 연속 모니터링 확보를 목적으로 방수 센서 등 선진 제품 개발에 주력하고 있습니다. 방수 센서는 물이나 땀에 노출되어도 정확하고 안정적으로 작동하도록 설계된 첨단 장치로 내부 부품을 잠재적인 손상으로부터 보호합니다. 예를 들어, 2024년 2월에는 미국에 본사를 둔 의료기기 제조업체인 덱스콤사가 스페인, 벨기에, 폴란드에서 실시간 연속 혈당 모니터링 시스템 「Dexcom ONE」을 발표했습니다. 이 시스템은 컴팩트하고 정확하고 사용자 친화적인 CGM 솔루션을 제공하며 사용자 정의 가능한 경보 기능(알람 피로를 최소화하는 자체 지연 우선 고혈당 알림 포함)을 통해 24 시간 시스템으로 실시간 혈당 측정을 제공합니다. 여러 장착 부위에 대응하는 방수 센서를 내장하여 30분의 신속한 워밍업 기간, 10일간의 센서 수명(교환을 위한 12시간 유예 기간 포함), 스마트폰 및 수신기와의 원활한 연결성을 특징으로 하여 효과적이고 지속적인 당뇨병 관리를 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

A real-time blood glucose continuous glucose monitoring (CGM) patch refer to a wearable medical device that continuously measures glucose levels in the interstitial fluid beneath the skin, providing real-time data. It helps individuals with diabetes track blood sugar trends, identify fluctuations, and make timely adjustments to insulin or diet for improved glycemic control. These patches minimize the need for frequent finger-prick tests while supporting proactive glucose management.

The key product types of real-time blood continuous glucose monitoring (CGM) patches include wearable continuous glucose monitoring patches and implantable continuous glucose monitoring patches. A wearable continuous glucose monitoring patch is a digital health device that continuously monitors glucose levels in real time via a sensor applied to the skin, aiding diabetes management, improving glycemic control, and supporting personalized treatment decisions. These patches use technologies such as enzymatic and non-enzymatic sensors and are applied across diabetes conditions including type 1 diabetes, type 2 diabetes, gestational diabetes, and others. They are distributed through channels such as online pharmacies, retail pharmacies, and hospital pharmacies, serving end users including hospitals, clinics, homecare settings, diagnostic centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The real-time blood glucose continuous glucose monitoring (CGM) patch market research report is one of a series of new reports from The Business Research Company that provides real-time blood glucose continuous glucose monitoring (CGM) patch market statistics, including real-time blood glucose continuous glucose monitoring (CGM) patch industry global market size, regional shares, competitors with a real-time blood glucose continuous glucose monitoring (CGM) patch market share, detailed real-time blood glucose continuous glucose monitoring (CGM) patch market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose continuous glucose monitoring (CGM) patch industry. This real-time blood glucose continuous glucose monitoring (CGM) patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The real-time blood glucose continuous glucose monitoring (cgm) patch market size has grown rapidly in recent years. It will grow from $6.41 billion in 2024 to $7.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth during the historical period can be attributed to the rising prevalence of diabetes, greater adoption of wearable healthcare devices, increasing demand for minimally invasive glucose monitoring solutions, and growing awareness of diabetes management and self-monitoring.

The real-time blood glucose continuous glucose monitoring (CGM) patch market size is expected to see rapid growth in the next few years. It will grow to $10.47 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth during the forecast period is driven by the rising demand for remote patient monitoring and telehealth solutions, increasing consumer interest in personalized healthcare solutions, growing preference for home-based healthcare monitoring, increasing focus on preventive healthcare and early intervention, and rising awareness of the advantages of continuous glucose monitoring over traditional methods. Primary trends in the forecast period include the development of personalized diabetes management platforms, integration with telemedicine systems for remote patient monitoring, integration with fitness trackers for comprehensive health insights, innovation in bio-compatible materials for longer wear and skin comfort, and integration with electronic health records for seamless clinician monitoring.

The rising adoption of remote monitoring and telehealth is expected to enhance the growth of the real time blood glucose CGM patch market in the coming years. Remote monitoring refers to the use of digital technologies to collect and transmit a patient's health data, such as blood glucose levels, heart rate, or blood pressure, from outside traditional clinical settings to healthcare providers for continuous assessment and management. Telehealth adoption involves the growing use of virtual healthcare services, including video consultations, remote follow ups, and digital communication between patients and healthcare providers. The adoption of remote monitoring and telehealth is increasing due to rising demand for convenient and accessible healthcare services, particularly for managing chronic conditions such as diabetes. Real time blood glucose CGM patches support this trend by enabling continuous, real time data sharing with healthcare providers, allowing timely interventions and effective virtual diabetes management. For example, in February 2025, according to the American Hospital Association, a U.S. based national organization, the United States is expected to face a shortage of up to 86,000 physicians by 2036, emphasizing the crucial role of telehealth in addressing this healthcare gap. Therefore, the rising adoption of remote monitoring and telehealth is enhancing the growth of the real time blood glucose CGM patch market.

Prominent players operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are emphasizing the development of advanced products, such as water-resistant sensors, to improve user convenience and ensure reliable continuous monitoring. A water-resistant sensor is an advanced device engineered to operate accurately and consistently even when exposed to water or perspiration, safeguarding its internal components from potential damage. For example, in February 2024, Dexcom Inc., a United States-based medical device manufacturer, introduced the Dexcom ONE+, a real-time continuous glucose monitoring system in Spain, Belgium, and Poland. The system delivers a compact, highly accurate, and user-friendly CGM solution that provides real-time glucose readings around the clock with customizable alerts, including a unique delay-first high notification to minimize alarm fatigue. It features an integrated water-resistant sensor compatible with multiple wear locations, a fast 30-minute warm-up period, a 10-day sensor life with a 12-hour grace window for replacement, and seamless connectivity to smartphones and receivers, facilitating effective and continuous diabetes management.

In April 2025, Cardinal Health Incorporated, a US-based healthcare company, acquired Advanced Diabetes Supply Group (ADSG) for an undisclosed amount. Through this acquisition, Cardinal Health aims to expand its at-home solutions business, reach more patients with innovative diabetes care, accelerate growth within the expanding diabetes population, and enhance patient-centric care delivery. Advanced Diabetes Supply Group is a US-based medical equipment distributor that provides real-time continuous glucose monitoring (CGM) patches.

Major players operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are Abbott Laboratories (FreeStyle), Dexcom Inc., F. Hoffmann-La Roche AG, Zhejiang POCTech Co. Ltd, Medtronic PLC, Senseonics Holdings, Inc. (Eversense), MicroTech Medical Inc., A. Menarini Diagnostics, Biolinq, Metronom Health, Medtrum Technologies Inc., Afon Technology, Nemaura Medical Inc., Ultrahuman Healthcare Pvt Ltd.

North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (CGM) patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the real-time blood glucose continuous glucose monitoring (CGM) patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as continuous glucose monitoring, data analysis and reporting, remote patient monitoring, device maintenance and calibration services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of long-wear continuous glucose monitoring patches, waterproof continuous glucose monitoring patches, wireless continuous glucose monitoring patches, pediatric continuous glucose monitoring patches, and multi-sensor continuous glucose monitoring patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Real-Time Blood Glucose CGM Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on real-time blood glucose cgm patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for real-time blood glucose cgm patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time blood glucose cgm patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Real-Time Blood Glucose CGM Patch Market Characteristics

3. Real-Time Blood Glucose CGM Patch Market Trends And Strategies

4. Real-Time Blood Glucose CGM Patch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Real-Time Blood Glucose CGM Patch Growth Analysis And Strategic Analysis Framework

6. Real-Time Blood Glucose CGM Patch Market Segmentation

7. Real-Time Blood Glucose CGM Patch Market Regional And Country Analysis

8. Asia-Pacific Real-Time Blood Glucose CGM Patch Market

9. China Real-Time Blood Glucose CGM Patch Market

10. India Real-Time Blood Glucose CGM Patch Market

11. Japan Real-Time Blood Glucose CGM Patch Market

12. Australia Real-Time Blood Glucose CGM Patch Market

13. Indonesia Real-Time Blood Glucose CGM Patch Market

14. South Korea Real-Time Blood Glucose CGM Patch Market

15. Western Europe Real-Time Blood Glucose CGM Patch Market

16. UK Real-Time Blood Glucose CGM Patch Market

17. Germany Real-Time Blood Glucose CGM Patch Market

18. France Real-Time Blood Glucose CGM Patch Market

19. Italy Real-Time Blood Glucose CGM Patch Market

20. Spain Real-Time Blood Glucose CGM Patch Market

21. Eastern Europe Real-Time Blood Glucose CGM Patch Market

22. Russia Real-Time Blood Glucose CGM Patch Market

23. North America Real-Time Blood Glucose CGM Patch Market

24. USA Real-Time Blood Glucose CGM Patch Market

25. Canada Real-Time Blood Glucose CGM Patch Market

26. South America Real-Time Blood Glucose CGM Patch Market

27. Brazil Real-Time Blood Glucose CGM Patch Market

28. Middle East Real-Time Blood Glucose CGM Patch Market

29. Africa Real-Time Blood Glucose CGM Patch Market

30. Real-Time Blood Glucose CGM Patch Market Competitive Landscape And Company Profiles

31. Real-Time Blood Glucose CGM Patch Market Other Major And Innovative Companies

32. Global Real-Time Blood Glucose CGM Patch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Real-Time Blood Glucose CGM Patch Market

34. Recent Developments In The Real-Time Blood Glucose CGM Patch Market

35. Real-Time Blood Glucose CGM Patch Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기